Navigation Links
Tor/Forge Launches THE CURE, a Riveting Thriller in the Tradition of Michael Crichton, by the New York Times Bestselling Author of WIRED.
Date:9/17/2013

(PRWEB) September 17, 2013

Tor/Forge today announced the hardcover and eBook launch of THE CURE, by New York Times bestselling author, Douglas E. Richards. THE CURE provides an eye-opening look at the science of psychopathy within an explosive, roller-coaster-ride of a novel that will keep both thriller fans, and science fiction fans, reading deep into the night. "Richards is a tremendous new talent," said Stephen Coonts, author of seventeen New York Times bestselling thrillers. "THE CURE is an extraordinarily good novel that will keep you riveted . . . and thinking."

Psychopaths seem to be at epidemic levels, and new research indicates their brains differ from those of normals, possibly accounting for their absolute selfishness, ruthlessness, and lack of conscience. And while most aren’t the Hannibal Lecter type, even the seemingly benign psychopaths among us inevitably leave a trail of shattered lives in their wakes.

“What if you could invent a simple way to diagnose this condition?” said Richards. “Would society be justified in monitoring psychopaths? Even before they’ve committed any crimes? What if you found the cure for this condition? While answers to these questions may seem straightforward, the deeper you dig, the more unexpected complexities you find.”

In THE CURE, Erin Palmer suffers through a devastating encounter with a psychopath as a child. Now a grad student and scientist, she’s devoting her life to studying these monsters. When her research catches the attention of Hugh Raborn, a brilliant neuroscientist who claims to have isolated the genes responsible for psychopathic behavior, Erin realizes it may be possible to reverse this condition, restoring souls to psychopaths. But to do so, she’ll not only have to operate outside of the law, but violate her most cherished ethical principles.

When Erin learns Raborn harbors dark secrets, all hell breaks loose. Is he working for the good of society? Or is he intent on bringing humanity to its knees?

Douglas E. Richards has been widely praised for his ability to weave action, suspense, and science into riveting novels that brilliantly straddle the thriller and science fiction genres. With THE CURE, Richards has done it again, penning a novel that, according to #1 New York Times bestselling author, Douglas Preston, "Will keep you turning the pages all night long."

THE CURE, released on September 17th, is available wherever books are sold.

To request a review copy, for more information, or to schedule an interview with the author, please contact Karen Lovell at 646.307.5409 or karen.lovell(at)tor(dot)com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11058161.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Meso Scale Discovery Launches V-PLEX™ Multiplex Biomarker Immunoassays
2. SPIE Launches New Symposium to Foster Dual-Use Sensor Technologies
3. CPUsage Launches Massive Scale Cloud Computing Platform at TechCrunch Disrupt
4. Salimetrics Launches a Better Salivary IL-6 ELISA/EIA Kit
5. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
6. University of Houston launches first nanotech company
7. Sciedu Press Launches New Journal for Management and Orgnaization Studies
8. BellBrook Labs Launches New Turn Key Methyltransferase Assay Kit for Oncogenic Histone Methyltransferase EZH2
9. Real Time Genomics Launches Two New Products in Human Disease Research
10. Clinovo Launches New Version of CDISC® Express, its CDISC SDTM Mapping Tool
11. ACRES Launches Global Clinical Research Network Technology Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Scientists propose in Nature ... in Gaucher and maybe other lysosomal storage diseases as ... than current therapies. An international research team ... which also included investigators from the University of Lübeck ... Feb. 22. The study was conducted in mouse models ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , ... from around the world, is pleased to announce the 2nd annual Precision Medicine ... This premier, online-only conference focused on the development and advancements in precision medicine. ...
(Date:2/22/2017)... MOINES, Iowa , Feb. 22, 2017 Origin (Origin ... agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and nutritional ... a key corn biotechnology product developed in China ... of global regulatory trials. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pharma and biotech ... as European director. Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins ... Pennside after more than a decade with leading market research firm, GfK. He ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):